Search research articles
Contact Us
Filters
Showing results (221-230 of 295) with videos related to
Page
of 30
Sort By:
Blood
|
August 14, 2015
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma
Chao Wang, Timothy W McKeithan, Qiang Gong, et al.
Blood
|
October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
Lisa M Rimsza, Robin A Roberts, Elias Campo, et al.
The American Journal of Surgical Pathology
|
January 26, 2011
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component
Carlo Visco, Sylvia Hoeller, Jeffrey T Malik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2019
L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma
Jiu-Yang Zhang, Pei-Pei Zhang, Wen-Ping Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab
Javeed Iqbal, Paul N Meyer, Lynette M Smith, et al.
Nature Communications
|
January 15, 2015
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Küçük, Bei Jiang, Xiaozhou Hu, et al.
Nature Communications
|
April 21, 2018
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
Olli Dufva, Matti Kankainen, Tiina Kelkka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
Javeed Iqbal, Vishala T Neppalli, George Wright, et al.
Nature
|
October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
Jagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Blood
|
March 1, 2012
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling
Karen E Deffenbacher, Javeed Iqbal, Warren Sanger, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 295) with videos related to
Sort By:
Page
of 30
Blood
|
August 14, 2015
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma
Chao Wang, Timothy W McKeithan, Qiang Gong, et al.
Blood
|
October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
Lisa M Rimsza, Robin A Roberts, Elias Campo, et al.
The American Journal of Surgical Pathology
|
January 26, 2011
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component
Carlo Visco, Sylvia Hoeller, Jeffrey T Malik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2019
L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma
Jiu-Yang Zhang, Pei-Pei Zhang, Wen-Ping Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab
Javeed Iqbal, Paul N Meyer, Lynette M Smith, et al.
Nature Communications
|
January 15, 2015
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Küçük, Bei Jiang, Xiaozhou Hu, et al.
Nature Communications
|
April 21, 2018
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
Olli Dufva, Matti Kankainen, Tiina Kelkka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
Javeed Iqbal, Vishala T Neppalli, George Wright, et al.
Nature
|
October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
Jagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Blood
|
March 1, 2012
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling
Karen E Deffenbacher, Javeed Iqbal, Warren Sanger, et al.
Page
of 30